EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Recent progress in the development of ursolic acid derivatives as anti‐diabetes and anti‐cardiovascular agents

Yili Dai iD, Linjun Sun, Yan Tan, Wenyu Xu, Shu Liu, Jing Zhou, Yalin Hu, Jieying Lin, Xu Yao, Pengbing Mi, Xing Zheng

Chemical Biology & Drug Design · 2023-12 · 102 (6) · 1643-1657

DOI: 10.1111/cbdd.14347 ↗

At a glance

Übersichtsarbeit in Chemical Biology & Drug Design, published online on 2023-09-13. Written by Yili Dai and 10 co-authors. Institution: Institute of Pharmacy and Pharmacology, Hengyang Medicinal School, University of South China, Hengyang, China. Major MEDLINE topics: Triterpenes. Cited 9 times so far (Crossref); 39 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Ursolic acid (UA) is a pentacyclic triterpenoid, which exhibits many biological activities, particularly in anti‐cardiovascular and anti‐diabetes. The further application of UA is greatly limited due to its low bioavailability and poor water solubility. Up to date, various UA derivatives have been designed to overcome these shortcomings. In this paper, the authors reviewed the development of UA derivatives as the anti‐diabetes anti‐cardiovascular reagents.

Subjects

MeSH terms (MEDLINE)

TriterpenesSolubilityUrsolic Acid

Author keywords

anti-cardiovascularanti-diabetesursolic acid derivatives

Substances

TriterpenesUrsolic Acid

Authors and institutions

  • Institute of Pharmacy and Pharmacology, Hengyang Medicinal School, University of South China, Hengyang, China.
  • Department of Pharmacy, Hunan Vocational College of Science and Technology, Changsha, China.

ORCID profiles: Yili Dai

Cite

APA

Dai, Y., Sun, L., Tan, Y., Xu, W., Liu, S., Zhou, J., Hu, Y., Lin, J., Yao, X., Mi, P., & Zheng, X. (2023). Recent progress in the development of ursolic acid derivatives as anti‐diabetes and anti‐cardiovascular agents. Chemical Biology & Drug Design, 102(6), 1643-1657. https://doi.org/10.1111/cbdd.14347

Vancouver

Dai Y, Sun L, Tan Y, Xu W, Liu S, Zhou J, et al. Recent progress in the development of ursolic acid derivatives as anti‐diabetes and anti‐cardiovascular agents. Chemical Biology & Drug Design. 2023;102(6):1643-1657. doi:10.1111/cbdd.14347

BibTeX
@article{Dai2023,
  author = {Dai, Yili and Sun, Linjun and Tan, Yan and Xu, Wenyu and Liu, Shu and Zhou, Jing and Hu, Yalin and Lin, Jieying and Yao, Xu and Mi, Pengbing and Zheng, Xing},
  title = {Recent progress in the development of ursolic acid derivatives as anti‐diabetes and anti‐cardiovascular agents},
  journal = {Chemical Biology & Drug Design},
  year = {2023},
  volume = {102},
  number = {6},
  pages = {1643--1657},
  doi = {10.1111/cbdd.14347}
}
Start for free →